(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of -22.27% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 13.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.
Assertio Holdings's revenue in 2024 is $152,069,000.On average, 1 Wall Street analysts forecast ASRT's revenue for 2024 to be $11,228,506,279, with the lowest ASRT revenue forecast at $11,228,506,279, and the highest ASRT revenue forecast at $11,228,506,279.
In 2025, ASRT is forecast to generate $12,938,431,093 in revenue, with the lowest revenue forecast at $12,938,431,093 and the highest revenue forecast at $12,938,431,093.